Literature DB >> 16257427

Hepatitis E antibody seroconversion without disease in highly endemic rural Egyptian communities.

Sonia K Stoszek1, Ronald E Engle, Mohamed Abdel-Hamid, Nabiel Mikhail, Fatma Abdel-Aziz, Ahmed Medhat, Alan D Fix, Suzanne U Emerson, Robert H Purcell, G Thomas Strickland.   

Abstract

Hepatitis E virus (HEV) is enterically transmitted and causes self-limiting acute viral hepatitis (AVH) primarily in less developed countries. A prospective cohort study to assess incidence of, and risk factors for, seroconversion to HEV (anti-HEV) was conducted in two Egyptian villages with a 67.7% anti-HEV prevalence. Nine hundred and nineteen villagers who were initially anti-HEV-negative were followed for 10.7 months. Thirty-four (3.7%) had strong anti-HEV serologic responses at follow-up giving an estimated anti-HEV incidence of 41.6/1,000 person-years. No significant associations were found between anti-HEV seroincidence and demographic and socioeconomic factors, source of water, household plumbing or sanitation, hand and vegetable washing, ownership of animals, jaundice and many other variables. None of the seroconverting subjects gave a history compatible with AVH during the interval. We hypothesize that both zoonotic and anthroponotic transmission of avirulent (possibly genotype-3) HEV is occurring extensively in these rural villages. An alternative explanation for the lack of morbidity among anti-HEV incident cases could be initial asymptomatic infections occur during early childhood with subsequent antibody titer boosting without illness upon re-exposure to the virus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16257427     DOI: 10.1016/j.trstmh.2005.05.019

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  33 in total

Review 1.  Liver Failure due to Acute Viral Hepatitis (A-E).

Authors:  Paul Manka; Jens Verheyen; Guido Gerken; Ali Canbay
Journal:  Visc Med       Date:  2016-04-07

2.  Hepatitis E: Epidemiology and prevention.

Authors:  Eyasu H Teshale; Dale J Hu
Journal:  World J Hepatol       Date:  2011-12-27

Review 3.  Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis E Virus Genotype 1 and 2 Infections.

Authors:  Rakesh Aggarwal; Amit Goel
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

Review 4.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

5.  The Association of Cytokines and Micronutrients with Hepatitis E Virus Infection During Pregnancy and the Postpartum Period in Rural Bangladesh.

Authors:  Brittany L Kmush; Alain Labrique; Wei Li; Sabra L Klein; Kerry Schulze; Saijuddin Shaikh; Hasmot Ali; Ronald E Engle; Lee Wu; Robert H Purcell; Sucheta Mehra; Parul Christian; Keith West; Kenrad Nelson
Journal:  Am J Trop Med Hyg       Date:  2015-11-30       Impact factor: 2.345

Review 6.  Hepatitis E and pregnancy: understanding the pathogenesis.

Authors:  Udayakumar Navaneethan; Mayar Al Mohajer; Mohamed T Shata
Journal:  Liver Int       Date:  2008-07-25       Impact factor: 5.828

Review 7.  Zoonotic hepatitis E: animal reservoirs and emerging risks.

Authors:  Nicole Pavio; Xiang-Jin Meng; Christophe Renou
Journal:  Vet Res       Date:  2010-04-02       Impact factor: 3.683

8.  A Study of Hepatitis E in Pregnancy: Maternal and Fetal Outcome.

Authors:  Gowri Sayi Prasad; Sayi Prasad; Ashok Bhupali; Ajit N Patil; Kanishtha Parashar
Journal:  J Obstet Gynaecol India       Date:  2015-08-22

9.  Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt.

Authors:  Jason T Blackard; Susan D Rouster; Soad Nady; Gehan Galal; Naglaa Marzuuk; Marwaa M Rafaat; Enas Daef; Salwa Seif El Din; Robert H Purcell; Suzanne U Emerson; Kenneth E Sherman; M Tarek Shata
Journal:  J Clin Virol       Date:  2009-08-03       Impact factor: 3.168

10.  Virulent strain of hepatitis E virus genotype 3, Japan.

Authors:  Kazuaki Takahashi; Hiroaki Okamoto; Natsumi Abe; Manri Kawakami; Hiroyuki Matsuda; Satoshi Mochida; Hiroshi Sakugawa; Yoshiki Suginoshita; Seishiro Watanabe; Kazuhide Yamamoto; Yuzo Miyakawa; Shunji Mishiro
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.